Merck Urges 9th Circ. To Reject Diabetes Drug Warning Claims
Merck and other drugmakers have urged the Ninth Circuit to uphold the toss of state-law claims that the companies failed to warn patients of pancreas problems from Type 2 diabetes drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article